Please login to the form below

Not currently logged in

Novavax plans to meet US COVID-19 vaccine demand in 2021

Company plans to produce two billion doses if vaccine proves effective

J&J inks $1bn deal with US for coronavirus vaccine

J&J cottonwood driveAgreement includes manufacturing and delivery of 100 million doses

Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops

GileadDisruption to uptake of HIV and hepatitis C drugs caused by pandemic

AstraZeneca escapes pandemic impact as new drugs bolster revenues

AstraZeneca AZEarnings climbed above expectations in the second quarter

Moderna looks to price COVID-19 vaccine at $50-$60 per course

Shines spotlight on pricing strategies for potential vaccines

Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine

AstraZeneca AZFollows initial deal agreed in June

Roche cites COVID-19 and biosimilars in Q2 decline

Roche Basel SwitzerlandPharmaceutical sales took a 4% hit in Swiss francs

Biogen raises full year guidance after beating Q2 expectations

BiogenKey drug franchises boost total revenues in the quarter

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

COVID-19 Updates and Daily News

Featured jobs


Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...